Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas
Stopped early · Phase 2
Conditions studied: Pancreatic Neoplasms
In brief
The goal is to assess survival and patterns of failure in patients treated with Gemzar-based chemoradiation and TNP-470 for locally advanced adenocarcinoma of the pancreas.
Key facts
- Study ID
- NCT00038701
- Run by
- M.D. Anderson Cancer Center
- People needed
- 6
- Starts
- 1999-08-01
- Expected to finish
- 2004-05-11
- Last updated by the study team
- 2018-11-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UT MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.